Earnings call transcript: KLA Q3 2026 beats forecasts but stock dips

KLA beat fiscal Q3 expectations with non-GAAP EPS of $9.40 versus $9.15 consensus and revenue of $3.415 billion versus $3.36 billion expected, while gross margin came in at 62.2%. Management raised the outlook, citing high-teen revenue growth for 2026, semiconductor process control growth above 20%, and advanced packaging revenue rising from about $635 million in 2025 to roughly $1 billion in 2026. The stock still fell 3.24% after hours amid valuation concerns, supply-chain/tariff headwinds, and a premium P/E near 49.8x.

Analysis

The key signal is not the beat; it’s the demand acceleration embedded in lead times. When a supplier with KLA’s visibility says the bottleneck is now fab construction and not customer appetite, that implies the capex cycle has shifted from cyclical ordering to capacity-discipline scarcity, which usually extends earnings power longer than consensus expects. The second-order effect is that process-control intensity rises faster than nominal wafer equipment spend, because every new node, packaging flow, and yield-recovery project requires disproportionate metrology/inspection spend.

The market reaction looks like classic quality-name de-rating after a strong run rather than thesis impairment. But the more important message is that valuation can compress while fundamentals inflect upward if the revenue mix shifts toward advanced packaging and service, which are structurally higher visibility than pure tool sales. That should support KLA’s multiple floor, but also likely keeps incremental upside capped unless the market becomes comfortable underwriting the 2027-2028 backlog conversion.

For peers, the read-through is mixed: Intel benefits if the industry’s yield-improvement spend is real, while foundry/memory customers face a larger productivity tax as they rush to secure capacity and tools. The market is underestimating how much of this cycle is now being pulled forward by AI infrastructure constraints, not just final demand; that creates a longer runway for semicap, but also raises the risk that suppliers hit execution limits before end-demand rolls over. The cleanest reversal catalyst would be any evidence that fab build-out, not order demand, starts to slow, which would surface first in lead-time commentary over the next 1-2 quarters.

Key Decisions for Investors

• Long KLAC vs short SOXX for 1-3 months: KLA has better visibility and pricing power than the basket, with upside if 2027 backlog commentary keeps improving; stop if industry WFE revisions flatten or lead times normalize faster than expected.
• Add to KLAC on further post-earnings weakness into the next 2-4 weeks: the multiple is vulnerable near term, but the fundamental inflection in advanced packaging and service supports a higher earnings base; target a rebound toward prior highs if the market re-rates backlog quality.
• Pair long KLAC / short INTC for 3-6 months: KLA captures the yield-and-process-control spend, while Intel remains more exposed to execution risk and capex dilution; this works best if “more tools per wafer” remains the dominant theme.
• Sell out-of-the-money KLAC put spreads 2-3 months out: take advantage of elevated post-earnings implied volatility and a strong fundamental floor, with defined risk in case of a broad semicap de-risking.
• Watch MSFT/GOOGL capex headlines as a catalyst pair: if hyperscaler capex decelerates meaningfully for two consecutive prints, trim semicap longs, because the market is currently overconfident that AI demand alone can absorb the entire upstream equipment cycle.